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INTRODUCTION
Vitellogenin (1, 2) is a sex-limited phosphopro-
tein secreted by the liver in Xenopus females (3, 4)
and selectively transferred via the circulatory
system to growing oocytes, within which it is
converted into the yolk proteins lipovitellin
and phosvitin (3, 5, 6) . Selective uptake (7)
and conversion (8) of vitellogenin can also take
place in isolated oocytes. The available evidence
indicates that vitellogenin is incorporated by a
micropinocytotic mechanism and that the de-
rived pinosomes subsequently fuse within the
cortex of the oocyte and give rise to yolk platelet
primordia (5, 9, 10). The conversion to lipo-
vitellin and phosvitin involves a macromolecular
restructuring within yolk platelet primordia
rather than breakdown and resynthesis (8, 11),
but the conversion mechanism remains unknown .
Protein synthesized by the developing oocyte
appears to undergo some degree of turnover
whereas sequestered vitellogenin does not (8).
This would imply that vitellogenin injected into
the cytoplasm of the oocyte might eventually
undergo breakdown rather than conversion
unless it could traverse the membranes of the
pinosomes and primordial yolk platelets . The
present report documents a test of this assumption
and indicates that indeed vitellogenin injected
into, rather than sequestered by, oocytes is not
converted to lipovitellin and phosvitin, but in-
stead appears to be simply catabolized .
METHODS
For the preparation of [ 3H, 32P]vitellogenin, approxi-
mately 400 pieces (I X 2 X 2 mm) obtained from
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the liver of a female that had been treated with
human chorionic gonadotropin (HCG) were in-
cubated in 20 ml of 50% Leibovitz L15 medium con-
taining 10% Xenopus male serum, antibiotics, 1 mCi
[3H]leucine, and 5 mCi carrier-free 32Pi as de-
scribed elsewhere (11). After 42 h at 20°C, the cul-
ture medium was carefully decanted, dialyzed
against 0.01 M citric acid-0.06 M 2-amino-2-
methyl-l-propanol(monol), centrifuged to remove
any debris, and placed on a TEAE-cellulose column
(29 X 1 .9 cm). [3H, 32P]vitellogenin was eluted
by the usual (1,000 ml) gradient procedure (12),
concentrated by ultrafiltration (12), and dialyzed
against solution 0 (13), all at 4°C. Samples of the
final preparation were placed on either Whatman
no. 42 or 3 MM filter paper disks and processed
for protein determination using Lab-trol (Dade
Div., American Hospital Supply Corp ., Miami, Fla.)
as a standard (14) or processed for scintillation count-
ing (8), respectively. The final labeled vitellogenin
preparation contained 26 cpm as 3H and 117 cpm
as 32P per ng protein as measured on disks containing
less than 25 µg protein .
Oocytes (0.9-1 .0 mm diam) were manually
dissected from the ovary of an HCG-treated female
(13). 60 oocytes were then either individually in-
jected with 21 nl of the labeled vitellogenin solution
(5 ng/nl), using micropipettes attached to a Zeiss
micromanipulator (Carl Zeiss, Inc., New York)
(15), or were incubated for 30 min in 0 .5 ml labeled
vitellogenin solution (0.15 mg/ml) and then in-
jected with 21 nl solution O. The injection of each
group of oocytes took 60-90 min. All oocytes were
then washed 3 times with solution 0 and, in order
to allow metabolism of [3H, 32P]vitellogenin to
take place, incubated for an additional 11 h in 50%
female Xenopus serum dialyzed against solution O.
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721Upon termination of the incubation period, oocytes
were briefly washed several times in solution 0,
transferred to 0.5 ml 1 .5 M NaCl in a small, tight-
fitting hand homogenizer, and thoroughly homoge-
nized. The homogenates were then centrifuged
(2,000 g) in the homogenizer for 30 min to remove a
small amount of insoluble material (mostly pigment),
and each supernatant was subsequently dialyzed
first against 0.01 M citric acid-0.06 M monol-
1 .0 M NaCl and then against 0.01 M citric acid-0.06
M monol. The dialyzed extracts were applied to a
small column (23 X 0.9 cm) of TEAE-cellulose
(8) and eluted with a 180-m1 3-bottle gradient
(7), using a flow rate of 0.6 ml/min. Samples (up
to 0.3 ml) of the effluent fractions were applied
with intermittent drying to disks and processed
with cold and hot trichloroacetic acid and alcohol-
ether for scintillation counting (8) . Each disk was
counted 10 times for 10 min . All data for 32P were
corrected for radioactive decay .
RESULTS AND DISCUSSION
[3H, 32P]vitellogenin with a high specific activity
was required for the experiment. This was ob-
tained by culturing liver slices from HCG-stimu-
lated females in the presence of isotopic precur-
sors and male serum (which lacks vitellogenin
[3]) . A small amount of [3H, 32P]vitellogenin was
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FIGURE 1 Chromatography on TEAE-cellulose of cul-
ture medium after incubation with female liver slices .
Almost the entire absorbance trace is contributed by
unlabeled male serum originally added to the culture
medium. Labeled serum proteins were synthesized and
secreted into the medium by the liver slices and are
indicated by the incorporation of [3H]leucine into pro-
tein. The most prominent component, vitellogenin,
elutes at position 0 .64 and is represented by only a very
small amount of protein contributed by the liver slices ;
it is the only component labeled by 32P; (1, 3) . The
arrows indicate the fractions collected for concentra-
tion.
secreted into the culture medium by the liver
slices over 42 h, but it was highly labeled by
[3H]leucine and specifically labeled by 32Pi
(Fig. 1). Its elution position was around 0.64,
which corresponds to our previous findings (3).
The fractions containing [3H, 32P]vitellogenin
were concentrated, dialyzed against solution 0,
and adjusted to a concentration of 0 .15 mg/ml.
Oocytes were then incubated in this medium for
30 min, after which they were washed and, as a
control procedure, injected with 21 nl solution
O. Under our usual incubation conditions, each
oocyte takes up about 0.70 µg vitellogenin/h
(8). At the more dilute concentration of labeled
vitellogenin used in this experiment, we have
determined that the rate of vitellogenin incor-
poration is about 25% as great, i.e., approxi-
mately 88 ng labeled vitellogenin was taken up
by each oocyte during the 30-min incubation
period .
After an additional 11-h incubation in un-
labeled medium, the labeled oocytes were ex-
tracted in strong salt and the dialyzed extract
was subsequently chromatographed on TEAE-
cellulose. The chromatograph (Fig. 2 a) indicated
that the principal components present were
the yolk proteins lipovitellin and phosvitin which
eluted at about positions 0.42 and 0.72, respec-
tively (compare with Fig . 7 in reference 3).
Labeling in the eluent fractions (Fig . 2 b) indi-
cated that [3H, 32P]vitellogenin was absent at
position 0.64 and that the 3H label and 32P label
were primarily associated with lipovitellin and
phosvitin, respectively, as would be expected
from the relative abundance of leucine and pro-
tein phosphate between the two yolk proteins
(2, 3, 8). Approximately 90% of the incorporated
labeled vitellogenin can be accounted for in the
elution profile.
[3H, 12P]vitellogenin was also prepared at a
concentration of 5.0 ng/nl, and 21 nl of this
solution was injected into individual oocytes
from the same female . Approximately 20% of
the injected material immediately leaked out of
the oocyte or was somehow lost during the sub-
sequent washings in solution O. In effect about
84 ng labeled vitellogenin was injected into each
oocyte or about the same amount that was in-
corporated by each oocyte during incubation
in solution 0 containing labeled vitellogenin .
The injected oocytes were then incubated for 11
h, extracted, and the dialyzed extracts wereE
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FIGURE 2 TEAE-cellulose chromatography of oocyte
extracts containing approximately 5 mg protein derived
from 60 oocytes. (a) Absorbance trace (b). Labeling in
extract from oocytes cultured in the presence of
[3H 32P]vitellogenin. (c) Labeling in extract from
oocytes injected with [3H, 32P]vitellogenin.
chromatographed and analyzed as was done pre-
viously. Although the absorbance profile ap-
peared the same (Fig. 2 a), labeling in the eluent
fractions (Fig. 2 c) indicated that no conversion
to lipovitellin or phosvitin had taken place.
Rather, a residual amount of labeled vitellogenin
was found at elution position 0.64 and small
amounts of heterogeneously labeled components
appeared throughout the chromatograph . The
amount of labeled vitellogenin found was less
than half of what would be expected if no break-
down had occurred, so it appears that most of
the injected vitellogenin was hydrolyzed into
small molecular weight products, some of which
were then incorporated into other macromolecules.
These results indicate that vitellogenin is
taken up by oocytes and converted into the yolk
proteins lipovitellin and phosvitin within a com-
M
partment different from and inaccessible to
vitellogenin injected into the oocyte cytoplasm .
Presumably this compartment is represented by
the membrane-bound pinosomes and the forming
yolk platelets.
Extracellular protein sequestered by other
types of cells has been found to undergo hydrol-
ysis within membrane-bound structures, appar-
ently through the agency of lysosomes (16-18) .
There does not appear to be a similar process in
vitellogenic oocytes, so either typical lysosomes
are absent or their activity is suppressed within
growing oocytes. Intracellular protein turnover
is less clearly understood ; most likely it may be
mediated either by autophagic vacuoles which
subsequently fuse with lysosomes (19, 20) or by
neutral proteases within the cytoplasm (21, 22) .
Acid phosphatase-containing structures and auto-
phagic vacuoles have been observed irregularly
in amphibian oocytes, but such oocytes may
have been atretic (23). It is apparent from pre-
vious results (8) and our present findings, how-
ever, that healthy, vitellogenic oocytes do en-
gage in intracellular protein turnover. Since
protein can be injected directly into an oocyte
and such protein clearly has a different fate from
that of sequestered protein, the vitellogenic oocyte
would appear to be an excellent model for the
study of both the compartmentalization and fate
of individual proteins administered to a living
cell by a variety of methods .
SUMMARY
Vitellogenin sequestered by vitellogenic oocytes
is not degraded but rather undergoes conversion
into the yolk proteins lipovitellin and phosvitin,
apparently within a membrane-bound com-
partment. Vitellogenin injected into oocytes is
not available to this compartment and is simply
degraded rather than converted . Although a
mechanism for protein catabolism thus exists
within the cytoplasm of growing oocytes, it may
not involve the agency of lysosomes.
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